Latest brain metastases Stories
Additional Data Demonstrate Accuray TomoTherapy and CyberKnife® Systems Provide Precise Dose Delivery and Tumor Management SUNNYVALE, Calif., Sept.
Multi-institutional radiotherapy planning study compared Leksell Gamma Knife Perfexion with three advanced linear-accelerator based stereotactic radiosurgery systems NEW YORK, May 21, 2014
Patients with five to 10 metastatic brain tumors who receive Gamma Knife radiosurgery live as long as those with two to four tumors post-therapy NEW YORK, May 13, 2014 /PRNewswire/
When treated with stereotactic radiosurgery (SRS), that is not combined with whole brain radiotherapy (WBRT), adult brain cancer patients who were 50 years old and younger were found to have improved survival.
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement.
A new drug being developed to treat potentially deadly melanoma skin cancers has shown a promising ability to shrink secondary tumors, known as metastases, in the brain in patients with advanced forms of the disease.
ATLANTA, July 1 /PRNewswire/ -- The refinements in Elekta's Gamma KnifeÂ® surgery technology that created the fifth generation Leksell Gamma KnifeÂ® Perfexion(TM) are radically changing the approach to treating brain metastases and other brain disorders.
MISSISSAUGA, ON, May 27 /PRNewswire-FirstCall/ - YM BioSciences Inc.
- A woman chauffeur.
- A woman who operates an automobile.